
Innovex International, Inc. (NYSE:INVX) (&#34;Innovex&#34; or the &#34;Company&#34;) today announced the pricing of an underwritten offering (the &#34;Offering&#34;) of 5,000,000 shares of its common stock by certain

<p xmlns="http://www.w3.org/1999/xhtml">
Innovex International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/INVX">INVX</a>) ("Innovex" or the "Company") today announced the pricing of an underwritten offering (the "Offering") of 5,000,000 shares of its common stock by certain affiliates of Amberjack Capital Partners, L.P. (the "Selling Stockholders"). Innovex will not sell any shares of its common stock in the Offering and will not receive any proceeds from the sale of the shares of its common stock being offered by the Selling Stockholders. The Offering is expected to close on August 10, 2026, subject to customary closing conditions.

</p><p xmlns="http://www.w3.org/1999/xhtml">
The underwriter intends to offer the shares from time to time for sale in one or more transactions on the New York Stock Exchange, in the over-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices.

</p><p xmlns="http://www.w3.org/1999/xhtml">
Barclays is acting as the sole underwriter for the Offering. The Offering is being made only by means of a prospectus supplement and the accompanying base prospectus, which was filed as part of a shelf registration statement on Form S-3 (File No. 333-282178), which was filed with the Securities and Exchange Commission (the "SEC") on September 17, 2024, and became effective on October 1, 2024. Before you invest, you should read the prospectus in that registration statement and other documents the Company has filed with the SEC for more complete information about the Company and the Offering. Copies of the preliminary prospectus supplement and accompanying base prospectus relating to the Offering, as well as copies of the final prospectus supplement once available, may be obtained for free on the SEC’s website at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=54585619&amp;newsitemid=20260806645782&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=1&amp;md5=02667a51a1ed1541e88372db3abc288d" shape="rect">www.sec.gov</a> or by contacting: Barclays Capital Inc. c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:barclaysprospectus@broadridge.com" shape="rect">barclaysprospectus@broadridge.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
This press release shall not constitute an offer to sell or a solicitation of an offer to buy the securities described above, nor shall there be any sale of these securities in any state or jurisdiction in which an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="bwuline">About Innovex International, Inc.</span></b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
Innovex International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/INVX">INVX</a>) is a Houston-based company established in 2024 following the merger of Dril-Quip, Inc. and Innovex Downhole Solutions, Inc. With locations throughout North America, Latin America, Europe, the Middle East and Asia, Innovex designs, manufactures, sells and rents mission critical engineered products to the global oil and natural gas industry.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="bwuline">Forward-Looking Statements</span></b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
Certain statements contained in this press release and oral statements made regarding the matters addressed in this release constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of Innovex’s control, that could cause actual results to differ materially from the results discussed in the forward-looking statements.

</p><p xmlns="http://www.w3.org/1999/xhtml">
Forward-looking statements can be identified by the use of forward-looking terminology including "may," "believe," "expect," "intend," "anticipate," "plan," "should," "estimate," "continue," "potential," "will," "hope" or other similar words and include the Company’s expectation of future performance contained herein. These statements discuss future expectations, contain projections of results of operations or of financial condition, or state other "forward-looking" information, including without limitation statements regarding the proposed Offering described above. You are cautioned not to place undue reliance on any forward-looking statements, which can be affected by assumptions used or by risks or uncertainties. Consequently, no forward-looking statements can be guaranteed. When considering these forward-looking statements, you should keep in mind the risk factors noted in the Company’s Annual Report on Form 10-K, any Quarterly Reports on Form 10-Q and the other documents that the Company files with the Securities and Exchange Commission. The risk factors and other factors noted therein could cause actual results to differ materially from those contained in any forward-looking statement. Innovex disclaims any duty to update and does not intend to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this press release, except as may be required by law.

</p><p xmlns="http://www.w3.org/1999/xhtml"><img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260806645782r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img><span xmlns="http://www.w3.org/1999/xhtml" class="bwct31415"></span></p><p xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink"><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-phrase">View source version on businesswire.com: </span><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-link"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260806645782/en/" rel="nofollow">https://www.businesswire.com/news/home/20260806645782/en/</a></span></p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="bwuline">Investor Relations Contact 
</span></b><br xmlns="http://www.w3.org/1999/xhtml"></br>Eric Wells
<br xmlns="http://www.w3.org/1999/xhtml"></br>Chief of Staff
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:investors@innovex-inc.com" shape="rect">investors@innovex-inc.com 
</a><br xmlns="http://www.w3.org/1999/xhtml"></br>(346) 398-0000

</p>

INVX

Innovex International, Inc. Announces Pricing of Underwritten Offering of 5,000,000 Shares of Common Stock by Selling Stockholders

Innovex to price 5M-share secondary by Amberjack affiliates; no proceeds to company

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>Innovex International, Inc. (NYSE:INVX) (&amp;#34;Innovex&amp;#34; or the &amp;#34;Company&amp;#34;) today announced the pricing of an underwritten offering (the &amp;#34;Offering&amp;#34;) of 5,000,000 shares of its common stock by certain</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Innovex announced the pricing of an underwritten offering for 5 million shares held by Amberjack Capital Partners affiliates. Innovex itself will not sell or receive proceeds, and the offering is expected to close on August 10, 2026 with Barclays as the sole underwriter. The move increases float without capital inflow, potentially putting near-term pressure on INVX stock as supply increases.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Innovex pricing an underwritten offering of 5 million shares by Amberjack affiliates.</li><li>Innovex will not sell or receive proceeds from the offering.</li><li>Underwriter Barclays Capital Inc. is sole underwriter; close expected August 10, 2026.</li><li>Sale may occur across NYSE/OTC or negotiated channels at market prices.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Innovex International, Inc. (INVX)</strong>: Issuing company; pricing of selling stockholders&#039; shares; no proceeds to issuer.</li><li><strong>Amberjack Capital Partners, L.P. (N/A)</strong>: Selling stockholders; impact on float and near-term price dynamics.</li><li><strong>Barclays Capital Inc. (BARC)</strong>: Sole underwriter; facilitates sale and price discovery.</li><li><strong>Dril-Quip, Inc. (DRQ)</strong>: Merged into Innovex in 2024; provides historical context for Innovex&#039;s oilfield focus.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>Category: Corporate Developments. The news centers on a secondary equity offering by selling stockholders, a corporate-financial event that can affect the stock’s immediate supply/demand dynamics and peer-type liquidity in the oil-and-gas equipment sector.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Sell-side dilution from the 5M-share offering could pressure INVX shares.</li><li>No cash proceeds to Innovex; valuation driven by market appetite and float expansion.</li><li>Barclays acts as sole underwriter; potential for temporary volatility around pricing.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Offering size: 5,000,000 shares.</li><li>Selling stockholders: affiliates of Amberjack Capital Partners, L.P.</li><li>Closing date: August 10, 2026 (subject to conditions).</li><li>Underwriter: Barclays Capital Inc. (sole underwriter).</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Bearish near-term for INVX due to a 5M-share secondary; monitor price action over the next 1–3 months.</p>
  </section>
</section>


<p xmlns="http://www.w3.org/1999/xhtml">
Innovex International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/INVX">INVX</a>) ("Innovex" or the "Company") today announced the pricing of an underwritten offering (the "Offering") of 5,000,000 shares of its common stock by certain affiliates of Amberjack Capital Partners, L.P. (the "Selling Stockholders"). Innovex will not sell any shares of its common stock in the Offering and will not receive any proceeds from the sale of the shares of its common stock being offered by the Selling Stockholders. The Offering is expected to close on August 10, 2026, subject to customary closing conditions.

</p><p xmlns="http://www.w3.org/1999/xhtml">
The underwriter intends to offer the shares from time to time for sale in one or more transactions on the New York Stock Exchange, in the over-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices.

</p><p xmlns="http://www.w3.org/1999/xhtml">
Barclays is acting as the sole underwriter for the Offering. The Offering is being made only by means of a prospectus supplement and the accompanying base prospectus, which was filed as part of a shelf registration statement on Form S-3 (File No. 333-282178), which was filed with the Securities and Exchange Commission (the "SEC") on September 17, 2024, and became effective on October 1, 2024. Before you invest, you should read the prospectus in that registration statement and other documents the Company has filed with the SEC for more complete information about the Company and the Offering. Copies of the preliminary prospectus supplement and accompanying base prospectus relating to the Offering, as well as copies of the final prospectus supplement once available, may be obtained for free on the SEC’s website at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=54585619&amp;newsitemid=20260806645782&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=1&amp;md5=02667a51a1ed1541e88372db3abc288d" shape="rect">www.sec.gov</a> or by contacting: Barclays Capital Inc. c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:barclaysprospectus@broadridge.com" shape="rect">barclaysprospectus@broadridge.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
This press release shall not constitute an offer to sell or a solicitation of an offer to buy the securities described above, nor shall there be any sale of these securities in any state or jurisdiction in which an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="bwuline">About Innovex International, Inc.</span></b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
Innovex International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/INVX">INVX</a>) is a Houston-based company established in 2024 following the merger of Dril-Quip, Inc. and Innovex Downhole Solutions, Inc. With locations throughout North America, Latin America, Europe, the Middle East and Asia, Innovex designs, manufactures, sells and rents mission critical engineered products to the global oil and natural gas industry.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="bwuline">Forward-Looking Statements</span></b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
Certain statements contained in this press release and oral statements made regarding the matters addressed in this release constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of Innovex’s control, that could cause actual results to differ materially from the results discussed in the forward-looking statements.

</p><p xmlns="http://www.w3.org/1999/xhtml">
Forward-looking statements can be identified by the use of forward-looking terminology including "may," "believe," "expect," "intend," "anticipate," "plan," "should," "estimate," "continue," "potential," "will," "hope" or other similar words and include the Company’s expectation of future performance contained herein. These statements discuss future expectations, contain projections of results of operations or of financial condition, or state other "forward-looking" information, including without limitation statements regarding the proposed Offering described above. You are cautioned not to place undue reliance on any forward-looking statements, which can be affected by assumptions used or by risks or uncertainties. Consequently, no forward-looking statements can be guaranteed. When considering these forward-looking statements, you should keep in mind the risk factors noted in the Company’s Annual Report on Form 10-K, any Quarterly Reports on Form 10-Q and the other documents that the Company files with the Securities and Exchange Commission. The risk factors and other factors noted therein could cause actual results to differ materially from those contained in any forward-looking statement. Innovex disclaims any duty to update and does not intend to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this press release, except as may be required by law.

</p><p xmlns="http://www.w3.org/1999/xhtml"><img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260806645782r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img><span xmlns="http://www.w3.org/1999/xhtml" class="bwct31415"></span></p><p xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink"><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-phrase">View source version on businesswire.com: </span><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-link"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260806645782/en/" rel="nofollow">https://www.businesswire.com/news/home/20260806645782/en/</a></span></p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="bwuline">Investor Relations Contact 
</span></b><br xmlns="http://www.w3.org/1999/xhtml"></br>Eric Wells
<br xmlns="http://www.w3.org/1999/xhtml"></br>Chief of Staff
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:investors@innovex-inc.com" shape="rect">investors@innovex-inc.com 
</a><br xmlns="http://www.w3.org/1999/xhtml"></br>(346) 398-0000

</p>

Innovex announced the pricing of an underwritten offering for 5 million shares held by Amberjack Capital Partners affiliates. Innovex itself will not sell or receive proceeds, and the offering is expected to close on August 10, 2026 with Barclays as the sole underwriter. The move increases float without capital inflow, potentially putting near-term pressure on INVX stock as supply increases.

News insight

Innovex International, Inc. Announces Pricing of Underwritten Offering of 5,000,000 Shares of Common Stock by Selling Stockholders

AI summary

Sentiment rationale

Key facts

Corporate Developments